CHAPTER 294 Lumbar Arthroplasty
Total Disk Replacement and Nucleus Replacement Technologies
Mechanical low back pain (LBP) because of lumbar degenerative disk disease (DDD) has been problematic to both diagnose and treat. Nonsurgical treatment is successful in the majority of patients with LBP.1–3 Unfortunately, a significant minority of patients at various stages of the degenerative cascade remain debilitated with diskogenic LBP. Surgical treatment for diskogenic LBP has traditionally focused on fusion with concomitant loss of function of the motion segment.4,5 Traditional lumbar fusion techniques have evolved over the years. The advent of increasingly sophisticated spinal instrumentation and implants have consistently increased fusion rates.6,7 Unfortunately, although fusion rates have approached 100%, clinical success rates have lagged significantly behind.4,8 Arthrodesis of the lumbar three-joint functional spinal unit (anterior disk and two posterior facet joints) results in loss of motion with a known incidence of adjacent level symptomatic degeneration ranging from 10% to 30%.9–15 Spine arthroplasty techniques allow for pain relief by removing presumed pain generators, the annulus and/or nucleus, while maintaining function (i.e. motion with uniform stress distribution) and, thereby, theoretically, protecting adjacent levels.
Partial disk replacement dates back to the 1960s, when Fernstrom implanted stainless steel balls into the cervical and lumbar spine.16 The modern era of lumbar arthroplasty was ushered in when Butner-Janz and Schellnack developed the original Charite artificial disk in the early 1980s.17 In the late 1980s, Marnay developed the Prodisc-L.18 Subsequently, total disk replacement has seen a steady evolution with a proliferation of devices and concomitant refinement in implant design, surgical technique, and instrumentation.
Nucleus replacement devices represent an even more heterogeneous group of devices and are earlier in the developmental process. Functionally, nucleus replacement devices can be divided into two broad classifications: elastomeric and mechanical (Fig. 294-1).16,19–21
The primary indication for both mechanical nucleus replacements and total disk replacement (TDR) is mechanical low back pain because of DDD.5 Elastomeric nucleus replacement can also be used in the post-discectomy setting.21
Generally, both types of nucleus replacement devices represent therapeutic interventions aimed at an early stage in the degenerative cascade (mild to moderate DDD). Advantages of nucleus replacement include minimally invasive and multiple approach options, including anterior retroperitoneal, lateral, and posterior approaches. Limited exposure and annulotomy allow for multiple revision options including TDR and fusion.19,20,22–26 Challenges of nucleus replacement include migration or expulsion risk (devices generally are not fixed to end plates) and subsidence.21,27–29
TDR is generally applicable for more advanced DDD (moderate to severe). Advantages of TDR include more definitive near-total disk removal that addresses pathology involving both the annulus and the nucleus as well as reliable fixation to bony end plates.30–33 Challenges of TDR include implant longevity, failure, and wear debris, as well as more challenging revision strategies (Table 294-1).34–37
NUCLEUS REPLACEMENT | TOTAL DISK REPLACEMENT |
---|---|
Limited annulotomy; nuclectomy only | Wide annulotomy; near-total discectomy |
Mild to moderate DDD | Moderate-to-severe DDD |
Anterior, lateral, posterior approach | Primarily anterior retroperitoneal approach |
No end plate fixation | End plate fixation |
Limited device surface area | Large device surface area |
Total Disk Replacement
Total Disk Replacement Devices
The Food and Drug Administration’s (FDA) approval of the Charite Artificial Disc in October 2004 ushered in the era of spinal arthroplasty in the United States.17 Subsequently, Prodisc-L (2006) and the next-generation Charite device, InMotion (2007), received FDA approval.35 Several more devices have followed (Maverick, Kineflex, FlexiCore, and Activ-L) with a number of others in various stages of development (Table 294-2). Cumulatively, these studies have produced a substantial body of level 1 data from prospective randomized studies confirming TDR’s efficacy in the treatment of symptomatic lumbar DDD.17,18,36,37
DEVICE MANUFACTURER TYPE | ||
METAL-ON-POLYMER | ||
Charite | Depuy Spine | Unconstrained |
InMotion | Depuy Spine | Unconstrained |
Prodisc-L | Synthes Spine | Semiconstrained |
Activ-L | Aesculap | Semiconstrained |
Mobi-L | LDR Spine | Unconstrained |
Triumph | Globus | Posterior |
Physio-L | Nexgen | Elastomeric |
CAdisc | Ranier Tech | Elastomeric |
eDisc | Theken | Elastomeric |
Dynardi | Zimmer | Semiconstrained |
Freedom | AxioMed | Elastomeric |
METAL-ON-METAL | ||
Maverick | Medtronic | Semiconstrained |
Kineflex | Spinal Motion | Semiconstrained |
FlexiCore | Stryker Spine | Fully constrained |
Lateral Disc | NuVasive | Lateral approach |
TrueDisc PL | Disc Motion Tech | Antenia posterior |
Charite Artificial Disc (Depuy Spine)
Cobalt chrome endplates with an unconstrained, polyethylene floating core and spike fixation. They have a three-piece design with a two-stage application and endplates followed by core placement (Fig. 294-2).
InMotion Artificial Disc (Depuy Spine)
The next-generation Charite device has redesigned end plates and a no-impaction application technique. The three-piece design has a single-stage application. The reconfigured cobalt chrome end plates and spike fixation have the same unconstrained, polyethylene floating core (Fig. 294-3).
Prodisc-L Artificial Disk (Synthes Spine)
The Prodisc-L has cobalt chrome end plates with a semiconstrained, polyethylene core and keel fixation and a three-piece design with a two-stage application (Fig. 294-4).
Maverick Artificial Disk (Medtronic)
The Maverick has a cobalt chrome, metal-on-metal design with semiconstrained ball and socket design with keel fixation (Fig. 294-5).